1. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence;Cherin;Autoimmun Rev,2016
2. Increased risk of adverse events when changing intravenous immunoglobulin preparations;Ameratunga;Clin Exp Immunol,2004
3. Criteria for the Use of Intravenous Immunoglobulin in Australia;National Blood Authority,2012
4. Intragam P Product Information Broadmeadows;CSL-Behring,2014
5. Intragam 10 Product Information Broadmeadows;CSL-Behring,2015